Personalized Medicine

Medicine, genetics and race: the case of cardiovascular diseases
pp. 1-6(6)
Author: Ordovas, Jose M

Gene mutation increases risk of late-onset Alzheimer's disease
pp. 7-10(4)

Individualizing warfarin therapy
pp. 11-31(21)
Authors: Reynolds, Kristen K; Valdes Jr, Roland; Hartung, Bronwyn R; Linder, Mark W

Risk-based and diagnostics-linked personalized medicine for cancer
pp. 33-43(11)
Authors: Srivastava, Sudhir; Wagner, Paul D

Mass spectrometry-based tissue proteomics for cancer biomarker discovery
pp. 45-58(14)
Authors: Balgley, Brian M; Wang, Weijie; De Voe, Don L; Lee, Cheng S

Age-related genetic abnormalities: the Achilles' heel for customizing therapy in elderly lung cancer patients
pp. 59-72(14)
Authors: Rosell, Rafael; Santarpia, Mariacarmela; Moran, Teresa; Salazar, Maria Fernanda; Kaen, Diego Lucas; Ramirez, Jose Luis

Personalized medicine: the absence of `model-changing' financial incentives
pp. 73-81(9)
Author: Keeling, Peter

Development of a warfarin-dosing algorithm in Asian patients: a pharmacogenomic approach
pp. 83-86(4)
Author: Aquilante, Christina L

Pharmacogenomics: single genes, whole genomes and global networks
pp. 87-94(8)
Author: Kennedy, Martin A

From human genetic variations to prediction of risks and responses to drugs and the environment
pp. 95-104(10)
Authors: Siest, Gérard; Bastien, B; Benachour, H; Herbeth, B; Jeannesson, E; Lambert, D; Samara, A; Visvikis-Siest, S

Pharma, clinicians and the lab come together over personalized medicine
pp. 105-108(4)
Author: Bukaveckas, Bonny Lewis